Core Laboratories (CLB) Earnings Date, Estimates & Call Transcripts $19.53 -0.42 (-2.11%) (As of 11/15/2024 08:54 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Core Laboratories Latest Earnings SummaryUpcoming Q4 Earnings DateJan. 29EstimatedActual EPS (Oct. 23) $0.25 Beat By $0.04 Consensus EPS (Oct. 23) $0.21 Core Laboratories released Q3 2024 earnings on October 23, 2024, reporting an EPS of $0.25, which beat analysts' consensus estimates of $0.21 by $0.04. Quarterly revenue rose 7.2% year-over-year to $134.40 million, above the consensus estimate of $134.16 million. With a trailing EPS of $0.65 and a P/E Ratio of 30.05, Core Laboratories' earnings are expected to grow 36.36% next year, from $0.77 to $1.05 per share. Conference Call TranscriptConference Call AudioCLB Upcoming EarningsCore Laboratories' next earnings date is estimated for Wednesday, January 29, 2025, based off prior year's reporting schedules. Get Core Laboratories Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Core Laboratories and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCLB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CLB Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Core Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.10$0.10$0.100.140 - 0.180Q2 20241$0.16$0.16$0.160.190 - 0.230Q3 20241$0.21$0.21$0.210.230 - 0.270Q4 20241$0.22$0.22$0.220.200 - 0.250FY 20244$0.69$0.69$0.69 Q1 20251$0.19$0.19$0.19 Q2 20251$0.27$0.27$0.27 Q3 20251$0.33$0.33$0.33 Q4 20251$0.33$0.33$0.33 FY 20254$1.12$1.12$1.12 Q1 20261$0.27$0.27$0.27 Q2 20261$0.24$0.24$0.24 Core Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 1/29/2025(Estimated)------- 10/23/2024Q3 2024$0.21$0.25+$0.04$0.29$134.16M$134.40M 7/24/2024Q2 2024$0.21$0.22+$0.01$0.25$132.85M$130.58M 4/24/2024Q1 2024$0.11$0.13+$0.02$0.19$124.47M$129.64M 1/31/2024Q4 2023$0.20$0.19 -$0.01$0.24$127.80M$128.21M 11/1/2023Q3 2023$0.23$0.22 -$0.01$0.25$129.81M$125.30M 7/26/2023Q2 2023$0.15$0.23+$0.08-$0.02$132.20M$127.88M The only candlestick pattern worth a darn (Ad)It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…Follow this link here and enter your email address to sign up…4/26/2023Q1 2023$0.14$0.08 -$0.06$0.11$126.26M$128.36M 2/2/2023Q4 2022$0.19$0.20+$0.01$0.32$130.12M$127.57M Core Laboratories Earnings - Frequently Asked Questions When is Core Laboratories's earnings date? Core Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based off last year's report dates. Learn more on CLB's earnings history. What guidance has Core Laboratories issued on next quarter's earnings? Core Laboratories updated its fourth quarter earnings guidance on Wednesday, October, 23rd. The company provided EPS guidance of $0.20-0.25 for the period, compared to the consensus EPS estimate of $0.24. The company issued revenue guidance of $128.5-135.5 million, compared to the consensus revenue estimate of $134.60 million. Did Core Laboratories beat their earnings estimates last quarter? In the previous quarter, Core Laboratories (NYSE:CLB) reported $0.25 earnings per share (EPS) to beat the analysts' consensus estimate of $0.21 by $0.04. Learn more on analysts' earnings estimate vs. CLB's actual earnings. How can I listen to Core Laboratories's earnings conference call? The conference call for Core Laboratories's latest earnings report can be listened to online. Listen to Conference Call How can I read Core Laboratories's conference call transcript? The conference call transcript for Core Laboratories's latest earnings report can be read online. Read Transcript How much revenue does Core Laboratories generate each year? Core Laboratories (NYSE:CLB) has a recorded annual revenue of $509.79 million. How much profit does Core Laboratories generate each year? Core Laboratories (NYSE:CLB) has a recorded net income of $36.67 million. CLB has generated $0.65 earnings per share over the last four quarters. What is Core Laboratories's price-to-earnings ratio? Core Laboratories (NYSE:CLB) has a trailing price-to-earnings ratio of 30.05 and a forward price-to-earnings ratio of 25.36. The price/earnings-to-growth ratio is 1.36. What is Core Laboratories's EPS forecast for next year? Core Laboratories's earnings are expected to grow from $0.77 per share to $1.05 per share in the next year, which is a 36.36% increase. ` More Earnings Resources from MarketBeat Related Companies BSM Earnings VRN Earnings LBRT Earnings CRGY Earnings TALO Earnings CLMT Earnings HPK Earnings WTTR Earnings DMLP Earnings VET Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! This page (NYSE:CLB) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
